Text Size
- News Releases
- What's New
- 21 Oct
- Tecentriq in Combination with Avastin Increases Overall Survival and Progression-free Survival as an Initial Treatment in People with Unresectable Hepatocellular Carcinoma
- 18 Oct
- Data on the use of Chugai’s Hemlibra in Hemophilia A Children with or without Inhibitors were Published in Journals
- 17 Oct
- Relief Efforts Support for Season's Nineteenth Typhoon
- 16 Oct
- Change in Designated Applicant under SAKIGAKE Designation System Concerning “Telomelysin (OBP-301),” Oncolytic Viral Immunotherapy
- 16 Oct
- F. Hoffmann-La Roche Announces Third Quarter Sales 2019
Video Introduction of CHUGAI- Share this site
